本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Monopar Therapeutics

109.87
+4.173.95%
盤後109.870.00000.00%19:53 EDT
成交量:22.98萬
成交額:2,470.91萬
市值:7.34億
市盈率:-57.18
高:110.23
開:105.47
低:103.00
收:105.70
52周最高:116.64
52周最低:29.18
股本:668.26萬
流通股本:411.75萬
量比:0.84
換手率:5.58%
股息:- -
股息率:- -
每股收益(TTM):-1.9216
每股收益(LYR):-1.8509
淨資產收益率:-15.86%
總資產收益率:-12.11%
市淨率:5.42
市盈率(LYR):-59.36

資料載入中...

公司資料

公司名字:
Monopar Therapeutics
交易所:
NASDAQ
成立時間:
2014
員工人數:
22
公司地址:
1000 Skokie Boulevard,Suite 350,Wilmette,Illinois,United States
郵編:
60091
電話:
傳真:
- -
簡介:
Monopar Therapeutics Inc.成立於2014年12月5日。該公司是一家臨床階段的生物製藥公司,開發威爾遜病的創新治療方法和腫瘤學的新型放射性藥物。

董事

名稱
職位
Chandler D. Robinson
Chief Executive Officer, Director
Christopher M. Starr
Executive Chairman, Director
Andrew P. Mazar
Executive Vice President of Research and Development, Chief Scientific Officer, Director
Arthur J. Klausner
Director
Michael J. Brown
Director
Raymond W. Anderson
Director

股東

名稱
職位
Chandler D. Robinson
Chief Executive Officer, Director
Kim R. Tsuchimoto
Chief Financial Officer, Secretary and Treasurer
Andrew P. Mazar
Executive Vice President of Research and Development, Chief Scientific Officer, Director
Christopher M. Starr
Executive Chairman, Director
Patrice Rioux
Acting Chief Medical Officer